| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0016-5085(98)70202-1 |
| P698 | PubMed publication ID | 9679041 |
| P2093 | author name string | Baeuerle PA | |
| Gross V | |||
| Schölmerich J | |||
| Vogl D | |||
| Andus T | |||
| Rogler G | |||
| Knuechel R | |||
| Page S | |||
| Brand K | |||
| Hofmeister R | |||
| P2860 | cites work | I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 |
| IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation | Q24321727 | ||
| IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK | Q24321797 | ||
| Constitutive NF-kappa B activity in neurons | Q28582881 | ||
| Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop | Q28645865 | ||
| NF-kappa B subunit-specific regulation of the interleukin-8 promoter | Q28646361 | ||
| Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B | Q28646362 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
| Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells | Q34377636 | ||
| Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis | Q34393256 | ||
| Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease | Q34409290 | ||
| Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum | Q34531935 | ||
| Catalysis by a multiprotein IkappaB kinase complex | Q34743658 | ||
| Functional analysis of the human vascular cell adhesion molecule 1 promoter | Q36232054 | ||
| Isolation and functional characterization of human intestinal mucosal lymphoid cells | Q37044471 | ||
| Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion | Q37353803 | ||
| An evolutionary and functional approach to the TNF receptor/ligand family | Q40699318 | ||
| Nuclear factor kappa B, a mediator of lipopolysaccharide effects | Q40825105 | ||
| NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. | Q40884567 | ||
| Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. | Q41204589 | ||
| Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody | Q41400651 | ||
| Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80 | Q42074128 | ||
| Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease | Q43973953 | ||
| A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride | Q48285770 | ||
| Enhanced mucosal cytokine production in inflammatory bowel disease | Q67531214 | ||
| Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease | Q68289394 | ||
| Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine | Q68350435 | ||
| Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease | Q70489716 | ||
| Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells | Q70578275 | ||
| Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice | Q71472065 | ||
| Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent | Q72188625 | ||
| Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis | Q72810439 | ||
| Alterations of the phenotype of colonic macrophages in inflammatory bowel disease | Q73841240 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 357-369 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa | |
| P478 | volume | 115 |
| Q34528979 | (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa |
| Q43651509 | (GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course |
| Q40545008 | 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity |
| Q36283368 | A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis |
| Q36344230 | A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice |
| Q44534172 | A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus |
| Q54754005 | A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. |
| Q38163844 | A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches |
| Q42924913 | AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis |
| Q28472412 | Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis |
| Q37590127 | Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. |
| Q47715550 | Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients |
| Q50077577 | Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization |
| Q35354271 | Activation of nuclear factor kappaB as a target for anti-inflammatory therapy |
| Q43004498 | Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. |
| Q43118458 | Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis |
| Q35594920 | Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease |
| Q57244639 | Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis |
| Q46437306 | Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers |
| Q50933699 | Alliin, a garlic organosulfur compound, ameliorates gut inflammation through MAPK-NF-κB/AP-1/STAT-1 inactivation and PPAR-γ activation |
| Q35802588 | Alloferon Alleviates Dextran Sulfate Sodium-induced Colitis |
| Q35467694 | Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide |
| Q52537292 | Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. |
| Q28555141 | Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model |
| Q64896713 | Anti-Ulcerogenic Properties of Lycium chinense Mill Extracts against Ethanol-Induced Acute Gastric Lesion in Animal Models and Its Active Constituents. |
| Q35875927 | Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling |
| Q41834622 | Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease |
| Q43407631 | Anti-proliferative, anti-inflammatory and antioxidant effects of curcumin analogue A₂. |
| Q64102569 | Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease |
| Q34473572 | Antisense approach to inflammatory bowel disease: prospects and challenges |
| Q40111828 | Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells |
| Q40752101 | Arsenite stabilizes IkappaBalpha and prevents NF-kappaB activation in IL-1 beta-stimulated Caco-2 cells independent of the heat shock response |
| Q88924937 | Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages |
| Q73535017 | Ascites of severe acute pancreatitis in rats transcriptionally up-regulates expression of interleukin-6 and -8 in vascular endothelium and mononuclear leukocytes |
| Q57436454 | Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations |
| Q48818660 | Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Behçet's disease |
| Q84286241 | Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis |
| Q86926202 | Astragaloside IV prevents lipopolysaccharide-induced injury in H9C2 cardiomyocytes |
| Q35067698 | Autophagosomal IkappaB alpha degradation plays a role in the long term control of tumor necrosis factor-alpha-induced nuclear factor-kappaB (NF-kappaB) activity. |
| Q38961202 | B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. |
| Q36809889 | Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation |
| Q36756653 | Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice |
| Q35360957 | Bax is downregulated in inflamed colonic mucosa of ulcerative colitis |
| Q36546684 | Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c mice |
| Q44575101 | Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease |
| Q36909385 | Biologics in Crohn's disease: searching indicators for outcome |
| Q42100170 | Bortezomib protects against dextran sulfate sodium‑induced ulcerative colitis in mice |
| Q28143405 | Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease |
| Q35595543 | CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. |
| Q49567330 | Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect |
| Q47927170 | Cathepsin D is up-regulated in inflammatory bowel disease macrophages. |
| Q80249795 | Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo |
| Q35357667 | Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease |
| Q40886663 | Cellular differentiation causes a selective down-regulation of interleukin (IL)-1beta-mediated NF-kappaB activation and IL-8 gene expression in intestinal epithelial cells |
| Q35168063 | Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia |
| Q37800675 | Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease |
| Q64249883 | Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection |
| Q34412280 | DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target |
| Q33699974 | Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients |
| Q35737476 | Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages |
| Q37532253 | Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice |
| Q41852528 | Design, Synthesis, and Testing of a Molecular Truck for Colonic Delivery of 5-Aminosalicylic Acid. |
| Q99555773 | Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract |
| Q32028300 | Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis |
| Q40737566 | Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium |
| Q24814806 | Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays |
| Q31394204 | Disturbed bile secretion and cytochrome P450 function during the acute state of experimental colitis in rats |
| Q39221260 | Diversity and functions of intestinal mononuclear phagocytes |
| Q26772342 | Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases |
| Q37719188 | ER stress and the unfolded protein response in intestinal inflammation. |
| Q42527548 | ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells |
| Q53225064 | Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice. |
| Q40635606 | Effect of selective PKC isoform activation and inhibition on TNF-alpha-induced injury and apoptosis in human intestinal epithelial cells |
| Q35161470 | Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in TNBS-induced colitis in rats |
| Q36973932 | Effects of Guchang Capsule on Dextran Sulphate Sodium-Induced Experimental Ulcerative Colitis in Mice |
| Q34151091 | Effects of dietary polyphenol-rich plant products from grape or hop on pro-inflammatory gene expression in the intestine, nutrient digestibility and faecal microbiota of weaned pigs |
| Q39506867 | Effects of mimic of manganese superoxide dismutase on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats |
| Q52728576 | Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells. |
| Q33556277 | Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation |
| Q34538014 | Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective |
| Q79356152 | Expression of NF-kappaB in Helicobacter pylori infection |
| Q36531919 | Expression of Transcription Factor FOXO3a is Decreased in Patients with Ulcerative Colitis |
| Q54341973 | Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis. |
| Q48681978 | Expression of functional NK-1 receptors in murine microglia |
| Q38313274 | Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry |
| Q53605478 | Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis. |
| Q40524225 | Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. |
| Q34009566 | Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease |
| Q89186432 | Fibrin patch influences the expression of hypoxia-inducible factor-1α and nuclear factor-κBp65 factors on ischemic intestinal anastomosis |
| Q38348120 | Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis |
| Q28236807 | Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells |
| Q37231612 | Functions of NOD-Like Receptors in Human Diseases |
| Q35670785 | G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation |
| Q59285953 | GPx2 Induction Is Mediated Through STAT Transcription Factors During Acute Colitis |
| Q34077080 | Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammation |
| Q36541173 | Gastrointestinal radiation injury: symptoms, risk factors and mechanisms |
| Q90706240 | Genetic Association between NFKBIA and NFKB1 Gene Polymorphisms and the Susceptibility to Head and Neck Cancer: A Meta-Analysis |
| Q52891216 | Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease? |
| Q33881932 | Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response |
| Q28484010 | Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells |
| Q40735478 | Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats |
| Q41650250 | Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease |
| Q39247105 | Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling |
| Q41034125 | Hepatoprotective Effect of Aqueous Extract from the Seeds of Orychophragmus violaceus against Liver Injury in Mice and HepG2 Cells |
| Q41216095 | How bacteria-induced apoptosis of intestinal epithelial cells contributes to mucosal inflammation |
| Q37508603 | Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response |
| Q39541011 | Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity |
| Q36769500 | Immune dysfunction in inflammatory bowel disease |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q55073227 | Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease. |
| Q40819983 | In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats |
| Q45237108 | In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway |
| Q34052951 | Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. |
| Q73082491 | Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice |
| Q43005389 | Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts |
| Q54762013 | Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. |
| Q40225845 | Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha |
| Q60511100 | Inflammation and Colorectal Cancer |
| Q29615500 | Inflammatory bowel disease |
| Q37258771 | Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. |
| Q42168920 | Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation |
| Q42926672 | Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC. |
| Q44039887 | Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine |
| Q40911348 | Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine |
| Q37907354 | Inhibitory kappa B Kinases as targets for pharmacological regulation |
| Q51333225 | Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? |
| Q41479687 | Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa |
| Q50498990 | Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells |
| Q27021395 | Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells |
| Q36399968 | Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. |
| Q37308981 | Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis |
| Q37292224 | Intestinal macrophages and response to microbial encroachment |
| Q45039592 | Lack of association of the 3'-UTR polymorphism in the NFKBIA gene with Crohn's disease in an Israeli cohort |
| Q46625014 | Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis |
| Q36977052 | Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. |
| Q34726793 | Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation |
| Q43262071 | Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor |
| Q40268445 | Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor |
| Q38773024 | Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation |
| Q36109503 | MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis |
| Q39404775 | MIP-3α expression in macrophages is NOD dependent |
| Q90401284 | Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
| Q73586025 | Maintaining gut homeostasis: the butyrate-NF-kappaB connection |
| Q36296995 | Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo |
| Q37692380 | Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease |
| Q73197599 | Mechanisms in failure of infliximab for Crohn's disease |
| Q26774688 | Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection |
| Q34894637 | Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis |
| Q30638019 | Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes |
| Q38644746 | Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. |
| Q46300890 | Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds |
| Q38953543 | Molecular pathways driving disease-specific alterations of intestinal epithelial cells |
| Q27004659 | Molecular profile of colorectal cancer in Indonesia: is there another pathway? |
| Q42524253 | Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. |
| Q34614244 | Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response |
| Q37949275 | Mucosal macrophages in intestinal homeostasis and inflammation |
| Q36709522 | NF-kappa B as a therapeutic target in autoimmune disease. |
| Q82277022 | NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats |
| Q36925725 | NF-kappaB and the intestine: friend or foe? |
| Q29614603 | NF-kappaB in cancer: from innocent bystander to major culprit |
| Q37163422 | NF-kappaB in inflammatory bowel disease |
| Q36631434 | NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach |
| Q63916236 | NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps |
| Q33930920 | NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases |
| Q58287167 | NF-κB Function in Inflammation, Cellular Stress and Disease |
| Q44429808 | NF-κB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells |
| Q37788597 | NF-κB and Mucosal Homeostasis |
| Q36795773 | NF-κB pathway in colitis-associated cancers |
| Q89348733 | NF-κB signaling in inflammation |
| Q53184998 | NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways. |
| Q40325258 | NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis |
| Q26777400 | Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease |
| Q38076049 | Negative regulation of human mononuclear phagocyte function |
| Q24669692 | Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease |
| Q38766138 | Nimbolide Inhibits Nuclear Factor-КB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice |
| Q47401453 | Novel effect of NF-kappaB activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium |
| Q26865584 | Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies |
| Q46086621 | Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers |
| Q40887968 | Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin |
| Q39476847 | Nuclear translocation of NF-κB in intact human gut tissue upon stimulation with coffee and roasting products |
| Q35013898 | Overcoming adherence issues in ulcerative colitis |
| Q35189234 | Ox-LDL induces dysfunction of endothelial progenitor cells via activation of NF-κB. |
| Q37827164 | Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. |
| Q38031537 | Oxidative stress in ulcerative colitis: an old concept but a new concern |
| Q44645442 | PKC-β1 isoform activation is required for EGF-induced NF-κB inactivation and IκBα stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers |
| Q30559414 | Paneth cells as a site of origin for intestinal inflammation. |
| Q42040140 | Par-complex aPKC and Par3 cross-talk with innate immunity NF-κB pathway in epithelial cells |
| Q44833660 | Paradoxical decrease of mitochondrial DNA deletions in epithelial cells of active ulcerative colitis patients |
| Q35742156 | Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling |
| Q28742767 | Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice |
| Q39458419 | Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. |
| Q44028015 | Pathways involved in mild gastrointestinal inflammation induced by a low level exposure to a food contaminant. |
| Q28085601 | Phytogenic compounds as alternatives to in-feed antibiotics: potentials and challenges in application |
| Q40776400 | Polyamine depletion induces rapid NF-kappa B activation in IEC-6 cells. |
| Q73774067 | Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease |
| Q34487187 | Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease |
| Q35607249 | Posttranslationally modified proteins as mediators of sustained intestinal inflammation |
| Q42709676 | Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. |
| Q54551350 | Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. |
| Q37387991 | Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression |
| Q55095896 | Propolis and Its Potential to Treat Gastrointestinal Disorders. |
| Q33264524 | Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis |
| Q35119930 | Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation |
| Q42242681 | Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats |
| Q46784817 | Protective effects of baicalin on ligature-induced periodontitis in rats |
| Q46930470 | Protein kinases, TNF-{alpha}, and proteasome contribute in the inhibition of fructose intestinal transport by sepsis in vivo. |
| Q50627076 | Pyloric gland metaplasia/differentiation in multiple organ systems in a patient with Peutz-Jegher's syndrome |
| Q90672269 | RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation |
| Q34616595 | Recent advances in understanding NF-kappaB regulation |
| Q36639759 | Recent understanding of IBD pathogenesis: implications for future therapies |
| Q36467014 | Regulation of apoptosis during homeostasis and disease in the intestinal epithelium |
| Q36457546 | Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. |
| Q41878721 | Role of NF-kappaB in immune and inflammatory responses in the gut. |
| Q26827637 | Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease |
| Q53565371 | Royal Jelly and its dual role in TNBS colitis in mice. |
| Q36353475 | Shigella dysenteriae infection activates proinflammatory response through β-catenin/NF-κB signaling pathway |
| Q64097047 | Short-chain Fatty Acids Inhibit Staphylococcal Lipoprotein-induced Nitric Oxide Production in Murine Macrophages |
| Q34600992 | Small therapeutic molecules for the treatment of inflammatory bowel disease |
| Q37354123 | Strategies to improve adherence and outcomes in patients with ulcerative colitis |
| Q41219004 | Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease |
| Q73356748 | Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells |
| Q28344913 | Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages |
| Q36691248 | Supplementation of a grape seed and grape marc meal extract decreases activities of the oxidative stress-responsive transcription factors NF-κB and Nrf2 in the duodenal mucosa of pigs |
| Q37192894 | Suppressing Syndecan-1 Shedding Ameliorates Intestinal Epithelial Inflammation through Inhibiting NF-κB Pathway and TNF-α |
| Q46542600 | Suppression of MAPKs/NF-κB Activation Induces Intestinal Anti-Inflammatory Action of Ginsenoside Rf in HT-29 and RAW264.7 Cells |
| Q47134033 | TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms |
| Q37724387 | Targeting NF-kappaB for colorectal cancer |
| Q35144028 | Targeting cytokines in autoimmunity: new approaches, new promise |
| Q43008147 | Tempol protects the gallbladder against ischemia/reperfusion |
| Q46441519 | Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation |
| Q34454532 | Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature |
| Q39484054 | The 100 classic papers in ulcerative colitis: a bibliometric analysis |
| Q81808494 | The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients |
| Q24336822 | The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO |
| Q55397547 | The Innate Immune System: A Trigger for Many Chronic Inflammatory Intestinal Diseases. |
| Q90664962 | The LPA2 receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroids |
| Q40159855 | The NOD2-RICK complex signals from the plasma membrane. |
| Q36611102 | The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis |
| Q86446578 | The anti-inflammatory potential of phenolic compounds in grape juice concentrate (G8000™) on 2,4,6-trinitrobenzene sulphonic acid-induced colitis |
| Q36052629 | The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells. |
| Q43004513 | The complicated path to true causes of disease: role of nuclear factor kappaB in inflammatory bowel disease |
| Q46120621 | The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease. |
| Q34574463 | The gut microflora and intestinal epithelial cells: a continuing dialogue |
| Q34966136 | The heat shock response and cytoprotection of the intestinal epithelium |
| Q38044907 | The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease |
| Q35048387 | The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. |
| Q40891401 | The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line |
| Q40660116 | The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. |
| Q98564280 | The relationship between preoperative T helper cytokines in the ileal mucosa and the pathogenesis of pouchitis |
| Q79157852 | The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling |
| Q46679822 | The role of the tumor necrosis factor receptor in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice |
| Q37332659 | Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis |
| Q30856787 | Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis |
| Q73381956 | Time course of colonic nuclear factor-kappa B expression during bacterial peptidoglycan-polysaccharide-induced colitis in rats |
| Q52858571 | Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. |
| Q28345627 | Transcription factor NF kappa B expression and postsurgical organ dysfunction |
| Q41779425 | Transglutaminase-catalyzed site-specific conjugation of small-molecule probes to proteins in vitro and on the surface of living cells |
| Q34136951 | Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling |
| Q34039324 | Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer |
| Q36321691 | Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases |
| Q84851901 | Ulcerative colitis |
| Q38202873 | Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer |
| Q36272303 | Upregulation of Toll-like receptor 2 and nuclear factor-kappa B expression in experimental colonic schistosomiasis |
| Q35773620 | Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection |
| Q36685523 | Wound healing and fibrosis in intestinal disease |
| Q49406138 | Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKKβ/NF-κB signaling in mice |
| Q37116354 | Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse |
| Q42510220 | ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells |
| Q89623393 | miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway |
Search more.